Nascent Biotech (OTC – NBIO) is slated to release in vitro studies that demonstrate its lead candidate may have an impact in treatment of coronaviruses as Pritumumab may have the ability to interfere with the virus’ binding to target cells, thus possibly eliminating deadly effects.

Data443 Risk Mitigation, Inc. (OTC - ATDS) is oversold, misunderstood, offers great value and significant upside potential, per our new 6 month price target

US-based and China focused Oranco, Inc. (OTC - ORNC) is growing top-line, very profitable, tradex at low price/book ,and is set yo execute M&A and an uplist later this year.

In our view, if leading China pork processor China Xiangtai Food Co., Ltd, (NASDAQ - PLIN) were to engage in a roll up strategy it could leap past its 52-week high. If it stayed on its current path, we believe 66% upside still lies ahead.

With Surge Holdings (OTC -SURG) set to enjoy a 300% increase in revenue to $100M+ in 2020, we have raised our forecasts and price target.

American Premium Water Corp (OTC - HIPH) just announced a transformational event for the company, going forward. Since our initiation a week ago, the stock is up 28% and based on the latest news we continue to affirm our target price and ivestment thesis.

With multiple products in the consumer products arena, particularly in the fast-growing, high profile CBD-infused products arena, HIPH is well positioned to generate meaningful sales across multiple sectors, in 2020.

In a follow up survey, Puration, Inc. (OTC - PURA) benefits from CBD buyers not changing their habits despite industry volatility.

Recent capital structure changes, tremendous positioning should drive Data443 Risk Mitgation, Inc. (OTC - ATDS) shares to new levels.

Our crypto survey results provide insights that are very positive for Alternet Systems (OTC -ALYI) and its strategy.